- Home
- CELC vs AROW Comparison
CELC vs AROW Comparison
Compare CELC & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- AROW
- Stock Information
- Founded
- CELC 2011
- AROW 1851
- Country
- CELC United States
- AROW United States
- Employees
- CELC N/A
- AROW N/A
- Industry
- CELC Medical Specialities
- AROW Major Banks
- Sector
- CELC Health Care
- AROW Finance
- Exchange
- CELC Nasdaq
- AROW Nasdaq
- Market Cap
- CELC 440.7M
- AROW 463.7M
- IPO Year
- CELC 2017
- AROW N/A
- Fundamental
- Price
- CELC $13.15
- AROW $26.40
- Analyst Decision
- CELC Strong Buy
- AROW Hold
- Analyst Count
- CELC 6
- AROW 1
- Target Price
- CELC $30.17
- AROW $30.00
- AVG Volume (30 Days)
- CELC 184.2K
- AROW 37.4K
- Earning Date
- CELC 03-26-2025
- AROW 01-30-2025
- Dividend Yield
- CELC N/A
- AROW 4.27%
- EPS Growth
- CELC N/A
- AROW 0.27
- EPS
- CELC N/A
- AROW 1.77
- Revenue
- CELC N/A
- AROW $134,626,000.00
- Revenue This Year
- CELC N/A
- AROW N/A
- Revenue Next Year
- CELC N/A
- AROW $7.29
- P/E Ratio
- CELC N/A
- AROW $14.81
- Revenue Growth
- CELC N/A
- AROW 3.11
- 52 Week Low
- CELC $10.35
- AROW $21.50
- 52 Week High
- CELC $22.19
- AROW $34.63
- Technical
- Relative Strength Index (RSI)
- CELC 60.85
- AROW 47.64
- Support Level
- CELC $12.55
- AROW $26.45
- Resistance Level
- CELC $13.25
- AROW $27.75
- Average True Range (ATR)
- CELC 0.68
- AROW 0.72
- MACD
- CELC 0.14
- AROW 0.08
- Stochastic Oscillator
- CELC 85.79
- AROW 65.79
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About AROW Arrow Financial Corporation
Arrow Financial Corp is a holding company. The company provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.